Hyperlipidaemia, stable angina, ACS and oedema Flashcards
What is QRISK2 used to calculate?
The 10-year risk of cardiac events.
What is JBS3 used to calculate?
Lifetime risk of cardiac events.
What percentage QRISK2 score is used to determine treatment?
10%+.
What compounds/drugs are not recommended for primary or secondary prevention of cardiovascular disease?
Fibrates, nicotinic acid, bile acid sequestrants, omega-3 fatty acid compounds.
Which individuals are at a high risk of developing cardiovascular disease?
Those with diabetes, hypertension, smokers, CKD, familial hypercholesterolaemia, age over 85.
What lifestyle changes should all people at a high risk of cardiovascular disease make?
Modifications to diet, exercise, weight-management, alcohol consumption, smoking cessation.
What is the first line treatment for primary prevention of cardiovascular disease if lifestyle measures are ineffective alone?
A statin.
What should be offered to all patients for the secondary prevention of cardiovascular disease?
A statin, combined with lifestyle advice.
What tests should be carried out before commencing statin treatment?
Total cholesterol, non-HDL cholesterol, LDL-cholesterol, HDL-cholesterol.
What is healthy range for total cholesterol?
Less than or equal to 5mmol/L.
What is the healthy range for non-HDL cholesterol?
Less than or equal to 4mmol/L.
What is the healthy range for LDL-cholesterol?
Less than or equal to 3mmol/L.
What is the healthy range for HDL-cholesterol?
Greater than or equal to 1mmol/L.
What is the first line treatment for hypercholesterolaemia, hypertriglyceridemia, and familial hypercholesterolaemia?
A statin.
If a statin alone is ineffective in the treatment of hypercholesterolaemia, hypertriglyceridemia, and familial hypercholesterolaemia, what may be added?
An additional lipid-controlling drug such as ezetimbe.
What may be added to treat resistant hyperlipidaemia?
Fenofibrates or nicotinic acid.
Statins are associated with an increased risk of muscle effects such as myopathy, myositis, and rhabdomyolysis. Which groups of patients are at a greater risk of this occurring?
Those with a family or personal history of muscle disorders, previous history of muscle toxicity, high alcohol intake, renal impairment, hypothyroidism, the elderly.
Combining a statin with which drugs leads to an increased risk of myopathy?
A fibrate or nicotinic acid.
Which antibiotic, seen in topical preparations, should be avoided in statin use?
Fucidic acid.
If fucidic acid is to be used by patients on statins, what course of action should be taken?
The statin should be stopped and restarted seven days after last dose.
Which drugs, when used with stating, increase the plasma concentration of said statin?
Macrolide antibiotics, imidazole and triazole antifungals, ciclosporin.
What monitoring is required for patients on statins?
Liver function and creatine kinase if muscular symptoms occur.
If severe muscular symptoms or raised creatine kinase occurs during statin treatment, what course of action should be taken?
Treatment should be discontinued. The statin should be reintroduced at a lower dose and the patient closely monitored. An alternative statin can be used if this is still not tolerated.
If patients being treated with a statin experience dyspnoea, cough, and weight loss, what should they do?
Seek medical attention. May be interstitial lung disease.
Correcting which metabolic condition may correct lipid abnormality?
Hypothyroidism.
Untreated hypothyroidism may increase the risk of what when lipid-regulating drugs are used?
Myositis.